Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/020911external-prioritypatent/WO2006002038A2/en
Application filedfiledCritical
Publication of GT200600501ApublicationCriticalpatent/GT200600501A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A OLIGONUCLEÓTIDOS INMUNOESTIMULADORES QUE COMPRENDEN AL MENOS UN DINUCLEÓTIDO SELECCIONADO DE C*PG, C*PG* Y CPG*, DONDE LA SECUENCIA DEL OLIGONUCLEÓTIDO ES AL MENOS PARCIALMENTE AUTOCOMPLEMENTARIA. ADEMÁS SIRVE PARA EL TRATAMIENTO DE VERTEBRADOS CON CÁNCER, DESÓRDENES INMUNOLÓGICOS COMO INFLAMACIÓN, PROBLEMAS DE PIEL, ALERGIAS, ASMA O ENFERMEDADES CAUSADAS POR PATÓGENOS.THE PRESENT INVENTION REFERS TO IMMUNOSTIMULATING OLIGONUCLEOTIDES THAT INCLUDE AT LEAST ONE SELECTED DINUCLEOTIDE OF C * PG, C * PG * AND CPG *, WHERE THE OLIGONUCLEOTIDE SEQUENCE IS AT LEAST PARTIALLY AUTOCOMPLEMENTARY. ALSO SERVES FOR THE TREATMENT OF VERTEBRATES WITH CANCER, IMMUNE DISORDERS AS INFLAMMATION, SKIN PROBLEMS, ALLERGIES, ASTHMA OR DISEASES CAUSED BY PATHOGENS.
Glucocorticoid derived compounds; preparation procedures; pharmaceutical composition; pharmaceutical combination; and use for the treatment of skin diseases such as eczema, nose, throat and lung conditions such as rhinitis or asthma, inflammatory bowel, eye and autoimmune diseases.